House dust mite allergy vaccine injection - Alk-AbelloAlternative Names: Alutard; Alutard Der p; Alutard SQ; House dust mite SCIT - ALk-Abello; TO-204
Latest Information Update: 22 Dec 2015
At a glance
- Originator ALK-Abello
- Developer ALK-Abello; Eddingpharm; Torii Pharmaceutical
- Class Allergens; Allergy immunotherapies; Antiallergics
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Asthma
- Registered Allergic rhinitis